Product image of Methotrexate Orion (Methotrexate) supplied by GNH India

Methotrexate Orion

Active Ingredient:
Methotrexate
Origin:
EU

Methotrexate Orion (Methotrexate)

Methotrexate, the active ingredient in Methotrexate Orion, is an Antimetabolite presented as an injectable solution for intramuscular and subcutaneous use. It interferes with folate metabolism, reducing DNA synthesis in rapidly dividing cells, and is employed to manage autoimmune disorders such as rheumatoid arthritis and psoriasis, as well as certain hematologic and solid‑tumor malignancies in adult and pediatric patients.

GNH India supplies Methotrexate Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, providing regulatory‑approved product documentation and logistics support for global distribution.

Manufacturer / TM Owner

Orion Corporation

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methotrexate is used in several disease categories where inhibition of cell proliferation is therapeutic.

  • Rheumatoid arthritis: reduces joint inflammation and slows disease progression.
  • Psoriasis: decreases skin cell turnover, improving plaque severity.
  • Acute lymphoblastic leukemia: impedes leukemic cell growth as part of chemotherapy regimens.
  • Other malignancies: used in combination protocols for various solid tumors and lymphomas.

How It Works

  • Methotrexate inhibits the enzyme dihydrofolate reductase, preventing the conversion of dihydrofolate to tetrahydrofolate. This reduction limits the availability of tetrahydrofolate‑dependent one‑carbon transfer reactions required for purine and pyrimidine synthesis, thereby blocking DNA, RNA and protein synthesis in rapidly dividing cells. The resulting antiproliferative effect underlies its immunosuppressive and anticancer activity. Additionally, at higher doses, methotrexate can increase extracellular adenosine, contributing to anti‑inflammatory effects.

Side Effects

Methotrexate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea and vomiting: gastrointestinal upset commonly reported.
  • Fatigue: persistent tiredness or weakness.
  • Mouth sores: ulceration of oral mucosa.
  • Elevated liver enzymes: mild transaminase increase.

Serious or Rare Side Effects

  • Bone marrow suppression: leading to anemia, leukopenia or thrombocytopenia.
  • Severe hepatotoxicity: risk of fibrosis or cirrhosis with prolonged use.
  • Pulmonary toxicity: interstitial pneumonitis or fibrosis.
  • Renal impairment: acute kidney injury especially with high doses.

Precautions & Warnings

When prescribing methotrexate, clinicians should observe several precautionary measures to minimize risk.

  • Baseline testing: obtain complete blood count, liver and renal function before initiation.
  • Monitoring: repeat laboratory tests regularly to detect hematologic or hepatic toxicity.
  • Concomitant folate: consider folic acid supplementation to reduce mucosal and hematologic side effects.
  • Pregnancy risk: avoid use in pregnancy due to potential teratogenicity; ensure effective contraception.
  • Drug interactions: review concurrent medications for known interactions that may increase toxicity.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Methotrexate interacts with several agents that can alter its efficacy or safety profile.

Major Interactions (Avoid)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase methotrexate toxicity by reducing renal clearance.
  • Proton pump inhibitors: may raise methotrexate plasma levels, especially in high‑dose regimens.
  • Trimethoprim‑sulfamethoxazole: potentiates bone marrow suppression.

Moderate Interactions (Monitor Closely)

  • Azathioprine or other immunosuppressants: additive myelosuppression risk.
  • Live vaccines: risk of infection due to immunosuppression.
  • Alcohol: may exacerbate hepatotoxicity.
  • Penicillins (e.g., ampicillin): can reduce renal excretion of methotrexate.

Frequently Asked Questions

Methotrexate Orion is indicated for the treatment of rheumatoid arthritis and psoriasis, as well as for certain cancers such as acute lymphoblastic leukemia and other malignancies where inhibition of rapidly dividing cells is required.

Methotrexate blocks the enzyme dihydrofolate reductase, reducing tetrahydrofolate production. This limits DNA, RNA and protein synthesis in fast‑growing cells, providing immunosuppressive and anticancer effects. At higher doses it also raises extracellular adenosine, contributing to anti‑inflammatory activity.

The prescribed dose is individualized by the treating physician based on the specific indication, patient weight, renal and hepatic function, and response to therapy. No standard dosing can be provided without a medical assessment.

Methotrexate is generally contraindicated in pregnancy because it can cause fetal malformations and miscarriage. Breastfeeding is also discouraged, as the drug may be excreted in milk and affect the infant. Women of child‑bearing potential should use effective contraception.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Unlike biologic agents that target specific cytokines, methotrexate acts at the cellular level by inhibiting folate metabolism, offering a broad immunosuppressive effect. It is generally less expensive but requires careful monitoring for toxicity, whereas biologics may have a different safety profile and administration route.

Methotrexate Orion should be stored at 2‑8 °C, protected from light, and kept in its original packaging. Do not freeze or shake the vial. If temperature excursions occur, consult the supplier before use.

The product is supplied for intramuscular or subcutaneous injection. Healthcare professionals should follow aseptic technique, select an appropriate injection site, and rotate sites to minimize local irritation. The exact injection volume and site are determined by the prescribing clinician.

Serious adverse events include bone‑marrow suppression (leading to anemia, leukopenia, thrombocytopenia), severe liver injury (fibrosis or cirrhosis), pulmonary toxicity (interstitial pneumonitis), and renal impairment. Prompt laboratory monitoring and clinical assessment are essential to detect these risks early.

Patients with known hypersensitivity to methotrexate, severe liver disease, uncontrolled infections, significant renal impairment, or those who are pregnant or planning pregnancy should avoid using Methotrexate Orion. Clinicians must evaluate each individual’s medical history before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methotrexate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT